en · de · es · pt
methods-notes.peptides4800.com › Topic › Detection, Stability, And Regulatory Status — Deep Dive

Detection, Stability, And Regulatory Status — Deep Dive

By Editorial Desk · published 2026-03-20 · last reviewed 2026-05-01 · Topic

If you have been reading about Thymosin beta-4 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2026-05-01. Where a claim depends on a specific study, the study is described rather than over-claimed.

Detection, Stability, and Regulatory Status

Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.

Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.

Handling Storage And Analysis

Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.

The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.

Tb-500 at a glance

PropertyValueNotes
Analytical methodLC-MS/MSPreferred confirmatory technique
AppearanceWhite to off-white powderLyophilised form
SolubilityFreely soluble in waterAlso described in saline
Storage temperatureBelow -20 °C for powderShort-term refrigeration for solutions
Regulatory statusProhibited in sportListed under peptide hormones

Thymosin Beta-4 Fragment Identity

TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.

Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.

No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.

Related pages on this site

TB-500 Background and Identity

The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.

Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.

TB-500 Identity and Naming Background

Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.

TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.

Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.

Further detail

Shulman (1943), biophysicist, Sterling Professor emeritus at Yale University Seymour Jonathan Singer (1943), cell biologist and professor at the University of California, San Diego Enoch Callaway (1943), psychiatrist, professor at the University of California, San Francisco Arnold Cooper (1944), psychoanalyst; professor at Weill Cornell Medical College and former president of the American Psychoanalytic Association Robert Jastrow (1944), astronomer, founder of NASA's Goddard Institute for Space Studies and conservative think tank George C. Marshall Institute Joshua Lederberg (1944), winner of the Nobel Prize in Physiology or Medicine Arnold Scheibel (1944), professor of neuroscience at the University of California, Los Angeles Alfred P. Wolf (1944), nuclear and organic chemist; research professor at New York University Paul Marks (1945), geneticist, president emeritus of the Memorial Sloan Kettering Cancer Center, former editor-in-chief of the Journal of Clinical Investigation Jack Oliver (1945), professor of seismology at Columbia University and Cornell University Malvin Ruderman (1945), physicist known for discovering the RKKY interaction Leonard Shengold (1946), psychiatrist at New York University known for study on child abuse Albert Starr (1946), cardiovascular surgeon, winner of the 2007 Lasker Award Arthur Ashkin (1947), winner of the Nobel Prize in Physics in 2018 Robert A. Frosch (1947), fifth administrator of the National Aeronautics and Space Administration Norton Zinder (1947), scientist who discovered bacterial transduction Frank I.

== United Kingdom == The Public Health Laboratory Service (PHLS) was established as part of the National Health Service in 1946. An Emergency Public Health Laboratory Service was established in 1940 as a response to the threat of bacteriological warfare. There was originally a central laboratory at Colindale and a network of regional and local laboratories. By 1955 there were about 1000 staff. These laboratories were primarily preventive with an epidemiological focus. They were, however, in some places located with hospital laboratories which had a diagnostic focus. The PHLS was replaced by the Health Protection Agency in 2003; the HPA was disbanded and in its stead was constituted Public Health England, which later became the UK Health Security Agency in 2021.

Transcription occurs in the nucleus using DNA as a template to produce mRNA. In eukaryotes, this mRNA molecule is known as pre-mRNA as it undergoes post-transcriptional modifications in the nucleus to produce a mature mRNA molecule. However, in prokaryotes post-transcriptional modifications are not required so the mature mRNA molecule is immediately produced by transcription.

Sources: en.wikipedia.org

Supporting material

=== Elastin and keratin === Elastin is a fibrous protein common in various soft tissues, like skin, blood vessels and lung tissue. Each monomer connects with each other, forming a 3D network, with ability to endure over 200% strain before deformation. Keratin is a structural protein mainly found in hair, nails, hooves, horns, quills. Basically keratin is formed by polypeptide chains, which coil into α-helices with sulfur cross-links or bond into β-sheets linked by hydrogen bonding. β-keratin, which is tougher than α-conformation, is more common in birds and reptiles.

=== Physical properties === A promethium atom has 61 electrons, arranged in the configuration [Xe] 4f5 6s2. The seven 4f and 6s electrons are valence electrons. In forming compounds, the atom loses its two outermost electrons and one 4f-electron, which belongs to an open subshell. The element's atomic radius is the second largest among all the lanthanides but is only slightly greater than those of the neighboring elements. It is the most notable exception to the general trend of the contraction of lanthanide atoms with the increase of their atomic numbers (lanthanide contraction). Many properties of promethium rely on its position among lanthanides and are intermediate between those of neodymium and samarium. For example, the melting point, the first three ionization energies, and the hydration energy are greater than those of neodymium and lower than those of samarium; similarly, the estimate for the boiling point, ionic (Pm3+) radius, and standard heat of formation of monatomic gas are greater than those of samarium and less than those of neodymium. Promethium has a double hexagonal close packed (dhcp) structure and a hardness of 63 kg/mm2. This low-temperature alpha form converts into a beta, body-centered cubic (bcc) phase upon heating to 890 °C.

== Reagan administration == President Ronald Reagan officially announced his war on drugs in October 1982. Reagan began to shift the job of drug enforcement from the state to the federal level. Reagan greatly increased the budgets of the antidrug programs in the FBI, the DEA, and the Department of Defense.

Sources: en.wikipedia.org

Supporting material

Attempts are being made to restore many of the city's best-maintained examples of pre-Soviet architecture. These restored structures are distinguished by bright colors and particularly clean façades. There are also a few examples of Soviet avant-garde work, such as the house of the architect Konstantin Melnikov in the Arbat area. Many of these restorations were criticized for allegedly disrespecting historical authenticity. In addition, facadism is widely practiced. Later examples of Soviet architecture are usually distinguished by large size and semi-Modernist styles. An example is the Novy Arbat project—informally called the "false teeth of Moscow"—and known for widespread disruption of the project's historic area in central Moscow.

== Further reading == Kielley WW, Bradley LB (1954). "Glutathione thiolesterase". J. Biol. Chem. 206 (1): 327–33. doi:10.1016/S0021-9258(18)71321-5. PMID 13130552. Murata, Kousaku; Sato, Nobuyuki; Rhee, Hae-ik; Watanabe, Kunihiko; Kimura, Akira (1987). "Purification and Characterization of Glutathione Thiol Esterase from Saccharomyces cerevisiae". Agricultural and Biological Chemistry. 51 (7): 1901–1907. doi:10.1080/00021369.1987.10868321. Uotila, Lasse (1979). "Glutathione thiol esterases of human red blood cells". Biochimica et Biophysica Acta (BBA) - Protein Structure. 580 (2): 277–288. doi:10.1016/0005-2795(79)90140-5. PMID 93000.

==== MeSH E05.820.150 – breeding ==== MeSH E05.820.150.360 – estrus detection MeSH E05.820.150.370 – estrus synchronization MeSH E05.820.150.390 – hybridization, genetic MeSH E05.820.150.520 – inbreeding

== External links == What's in an Oil Drop? An Introduction to Fourier Transform Ion Cyclotron Resonance (FT-ICR) for Non-scientists National High Magnetic Field Laboratory Scottish Instrumentation Resource Centre for Advanced Mass Spectrometry Fourier-transform Ion Cyclotron Resonance (FT-ICR) FT-ICR Introduction University of Bristol

Sources: en.wikipedia.org

Frequently asked questions

How is the peptide detected in samples?

The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.

How should the powder be stored?

Dry lyophilised powder is normally kept frozen and protected from moisture and light. Dissolved material is handled cold and used promptly to limit degradation.

Is it approved for medical use?

It is not licensed as a medicine in major markets and is distributed as a research chemical. Sports organisations prohibit its use, and some countries restrict import and supply.

How should a stock solution be kept between uses?

Divide it into single-use aliquots and hold them frozen at -20 °C or below, protected from light. Repeated thawing of one container is the main avoidable source of variability.

Network